Literature DB >> 30016401

Sex-specific regulation of collagen I and III expression by 17β-Estradiol in cardiac fibroblasts: role of estrogen receptors.

Elke Dworatzek1,2, Shokoufeh Mahmoodzadeh2,3, Cindy Schriever3, Kana Kusumoto1, Lisa Kramer1,2, Gabriela Santos4,5, Daniela Fliegner6, Yuet-Kin Leung7, Shuk-Mei Ho7, Wolfram-Hubertus Zimmermann4,5, Susanne Lutz4,5, Vera Regitz-Zagrosek1,2.   

Abstract

Aims: Sex differences in cardiac fibrosis point to the regulatory role of 17β-Estradiol (E2) in cardiac fibroblasts (CF). We, therefore, asked whether male and female CF in rodent and human models are differentially susceptible to E2, and whether this is related to sex-specific activation of estrogen receptor alpha (ERα) and beta (ERβ). Methods and results: In female rat CF (rCF), 24 h E2-treatment (10-8  M) led to a significant down-regulation of collagen I and III expression, whereas both collagens were up-regulated in male rCF. E2-induced sex-specific collagen regulation was also detected in human CF, indicating that this regulation is conserved across species. Using specific ERα- and ERβ-agonists (10-7 M) for 24 h, we identified ERα as repressive and ERβ as inducing factor in female and male rCF, respectively. In addition, E2-induced ERα phosphorylation at Ser118 only in female rCF, whereas Ser105 phosphorylation of ERβ was exclusively found in male rCF. Further, in female rCF we found both ER bound to the collagen I and III promoters using chromatin immunoprecipitation assays. In contrast, in male rCF only ERβ bound to both promoters. In engineered connective tissues (ECT) from rCF, collagen I and III mRNA were down-regulated in female ECT and up-regulated in male ECT by E2. This was accompanied by an impaired condensation of female ECT, whereas male ECT showed an increased condensation and stiffness upon E2-treatment, analysed by rheological measurements. Finally, we confirmed the E2-effect on both collagens in an in vivo mouse model with ovariectomy for E2 depletion, E2 substitution, and pressure overload by transverse aortic constriction.
Conclusion: The mechanism underlying the sex-specific regulation of collagen I and III in the heart appears to involve E2-mediated differential ERα and ERβ signaling in CFs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30016401      PMCID: PMC6933535          DOI: 10.1093/cvr/cvy185

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  49 in total

1.  Sex-dependent differences in left ventricular function and structure in chronic pressure overload.

Authors:  B Villari; S E Campbell; J Schneider; G Vassalli; M Chiariello; O M Hess
Journal:  Eur Heart J       Date:  1995-10       Impact factor: 29.983

2.  The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter.

Authors:  J T Norman; G E Lindahl; K Shakib; A En-Nia; E Yilmaz; P R Mertens
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

3.  Regression of myocardial hypertrophy after aortic valve replacement: faster in women?

Authors:  George Petrov; Vera Regitz-Zagrosek; Elke Lehmkuhl; Thomas Krabatsch; Anne Dunkel; Michael Dandel; Elke Dworatzek; Shokoufeh Mahmoodzadeh; Carola Schubert; Eva Becher; Hannah Hampl; Roland Hetzer
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

4.  Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study.

Authors:  Ashild Bjørnerem; Bjørn Straume; Monica Midtby; Vinjar Fønnebø; Johan Sundsfjord; Johan Svartberg; Ganesh Acharya; Pål Oian; Gro K Rosvold Berntsen
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

5.  Membrane ERα attenuates myocardial fibrosis via RhoA/ROCK-mediated actin remodeling in ovariectomized female infarcted rats.

Authors:  Tsung-Ming Lee; Shinn-Zong Lin; Nen-Chung Chang
Journal:  J Mol Med (Berl)       Date:  2013-11-29       Impact factor: 4.599

6.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

7.  Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.

Authors:  Ping Zhu; Sung Hee Baek; Eliot M Bourk; Kenneth A Ohgi; Ivan Garcia-Bassets; Hideki Sanjo; Shizuo Akira; Paul F Kotol; Christopher K Glass; Michael G Rosenfeld; David W Rose
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

8.  Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement.

Authors:  George Petrov; Elke Dworatzek; Tabea Marie Schulze; Michael Dandel; Georgios Kararigas; Shokufeh Mahmoodzadeh; Christoph Knosalla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  JACC Cardiovasc Imaging       Date:  2014-10-08

9.  Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.

Authors:  Christina Westphal; Carola Schubert; Katja Prelle; Adam Penkalla; Daniela Fliegner; George Petrov; Vera Regitz-Zagrosek
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

10.  Sex-specific pathways in early cardiac response to pressure overload in mice.

Authors:  Henning Witt; Carola Schubert; Juliane Jaekel; Daniela Fliegner; Adam Penkalla; Klaus Tiemann; Joerg Stypmann; Stefan Roepcke; Sebastian Brokat; Shokoufeh Mahmoodzadeh; Eva Brozova; Mercy M Davidson; Patricia Ruiz Noppinger; Christian Grohé; Vera Regitz-Zagrosek
Journal:  J Mol Med (Berl)       Date:  2008-07-30       Impact factor: 4.599

View more
  34 in total

Review 1.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Santosh Kumari; Bakhtiyor Yakubov; Andrea L Frump; Timothy A Hacker; Alessandro Bellofiore; Rongbo Li; Xin Sun; Kara N Goss; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

Review 3.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

4.  Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction.

Authors:  Anis Hanna; Arti V Shinde; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-04       Impact factor: 4.733

5.  Application of estrogen for the treatment of stress urinary incontinence in mice.

Authors:  Lu Li; Shasha Hong; Li Hong; Yang Li; Xiang Li; Lian Yang; Jianfeng Liu
Journal:  Arch Gynecol Obstet       Date:  2022-02-16       Impact factor: 2.344

Review 6.  Sex Differences in Myocardial and Vascular Aging.

Authors:  Hongwei Ji; Alan C Kwan; Melanie T Chen; David Ouyang; Joseph E Ebinger; Susan P Bell; Teemu J Niiranen; Natalie A Bello; Susan Cheng
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

Review 7.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

Review 8.  Sex differences in cardiometabolic disorders.

Authors:  Eva Gerdts; Vera Regitz-Zagrosek
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

Review 9.  Non-ischemic dilated cardiomyopathy and cardiac fibrosis.

Authors:  Bianca Olivia Cojan-Minzat; Alexandru Zlibut; Lucia Agoston-Coldea
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

10.  Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.

Authors:  Jennifer J DuPont; Seung Kyum Kim; Rachel M Kenney; Iris Z Jaffe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-23       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.